ロード中...
From Monoclonal Antibodies to Chimeric Antigen Receptors for the Treatment of Human Malignancies
Monoclonal antibodies (mAbs) and their directly derived cell-based application known as chimeric antigen receptors (CARs) ensue from the need to develop novel therapeutic strategies that retain high anti-tumor activity, but carry reduced toxicity compared to conventional chemo- and radio-therapies....
保存先:
| 出版年: | Semin Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4254449/ https://ncbi.nlm.nih.gov/pubmed/25440610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2014.08.005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|